RDEA
Ardea Biosciences Inc
Biotechnology company developing treatments for gout, notably lesinurad; acquired by AstraZeneca in 2012
CUSIP: 03969P107HealthcareUS1 holder
Total Value
$2.17M
Total Shares
210.4K
Net Share Change
+210.4K
Activity
1 buying
Investor
Value
Shares
Weight
Change
